ECO Animal Health Group PLC
David Nicholas has a diverse work experience spanning several industries. David currently serves as the Director of Operations Consultancy at ECO ANIMAL HEALTH GROUP PLC since September 2019. Prior to this, they were the owner of Bay Research Services Ltd, providing research and development consultancy to the human health and veterinary medicine industries. David has held various leadership positions at Syneos Health Clinical Solutions and inVentiv Health Clinical. Before that, they had a long tenure with Pfizer, where they held multiple roles in clinical operations, project management, regulatory affairs, and veterinary medicine.
David Nicholas has a Post Graduate Diploma in Applied Pharmacology from the University of East London. No other information regarding their education history is available.
This person is not in any teams
ECO Animal Health Group PLC
Eco Animal Health Group plc is engaged in the development, registration and marketing of pharmaceutical products for global animal health markets. The Company's principal activity is the manufacture and supply of animal health products across the globe. These activities are conducted on a global scale, through a network, including both regional offices (notably in Shanghai and Princeton) and overseas subsidiaries. The Company's products include Aivlosin and Ecomectin. Aivlosin is an antibiotic that treats a range of specific enteric (gut) and respiratory diseases in pigs and poultry. Ecomectin is an endectocide that controls worms, ticks, lice and mange in grazing stock and pigs. It operates in the United Kingdom and Europe, the Far East, Latin America, North America, and the Middle East and Africa. Its subsidiaries include Eco Animal Health Limited and ECO Animal Health do Brasil Comercio de Produtos Veterinarios Ltda.